Home About Us Contact Us

 

Table of Content - Volume 10 Issue 1 - April 2018


 

A study on prevalence of microalbuminuria and its correlates in patients with essential hypertension

 

Udai Hirdaya Mohan Lal1, Channappa K C2*, Ajay Kumar Reddy Bobba3

 

1Associate Professor, Department of General Medicine, Mediciti Institute of Medical Sciences, Hyderabad, INDIA.

2Associate Professor, Department of General Medicine, Sapthagiri Institute of Medical Sciences & Research Centre, Bengaluru, INDIA.

3Assistant Professor, Department of Community Medicine, Alluri Sitarama Raju Academy of Medical Sciences, Eluru, Andhra Pradesh.

Email: drkcchannappa@gmail.com

 

REFERENCES

  1. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol. 1997,80:164-9.
  2. Global Health Observatory (GHO) data. India: country profiles. https://www.who.int/nmh/countries/ind_en.pdf?ua=1 (last accessed on 11/02/2019).
  3. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence ofmicroalbuminuria in a large population of patients withmild to moderate hypertension. Nephron 1992; 61:94-7.
  4. Aggarwal HK, Jain D, Mor S, Yadav RK, Jain P. Prevalence and Clinical Correlates of Microalbuminuria in Patients with Essential Hypertension-A Tertiary Care Center Cross Sectional Study. J Association Physicians India. 2016.
  5. Bianchi S, Bigazzi R, Campese VM. Microalbuminuria inessential hypertension: Significance, pathophysiology, andtherapeutic implications. Am J Kidney Dis 1999; 34: 973‑95.
  6. Plavnik FL, Silva MA, Kohlmann NE, Kohlmann O Jr., Ribeiro AB, Zanella MT. Relationship between microalbuminuriaand cardiac structural changes in mild hypertensive patients. Braz J Med Biol Res 2002;35:799-804.
  7. Basi S, Fesler P, Mimran A, Lewis JB. Micro-albuminuria in Type 2 Diabetes and Hypertension. A marker, treatment target, or innocent bystander? Diabetes Care. 2008; 31 Suppl2:S 194-201.
  8. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000; 35: 898-903.
  9. Pedrinelli R, Penno G, Dell'Omo G, Bandinelli S, Giorgi D, Di Bello V. Micro-albuminuria and transcapillary albumin leakage in essential hypertension. Hypertension. 1999; 34: 491-5.
  10. De Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am SocNephrol. 2006; 17: 2100-5.
  11. Summerson J, Bell R, Konen J. Racial differences in the prevalence of microalbuminuria in hypertension. Am JKidney Dis 1995; 26:577-9.
  12. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A,et al. Prevalence and clinical correlates of microalbuminuriain essential hypertension: The MAGIC Study. Hypertension1997; 30:1135-43.
  13. Tagore PK, Gupta A, Kumar D, Yadav MS. Correlates of microalbuminuri a in hypertensive patients of a tertiary care teaching hospital of Centra l India. International Journal of Research in Medical Sciences. 2016 Aug; 4(8):3402.
  14. Habbal R, Sekhri AR, Volpe M, i-Search Investigators. Prevalence of microalbuminuria in hypertensive patients and its associated cardiovascular risk in clinical cardiology: Moroccan results of the global i-SEAR CH survey–a sub-analysis of a survey with 21 050 patients in 26 countries worldwide. Cardiovascular journal of Africa. 2010 Aug; 21(4):200.
  15. Nwegbu MM, Akintan GA, Irabor EO. Prevalence of microalbuminuria in newly diagnosed hypertensives in a tertiary hospital setting, using a semi-quantitative screening tool. International Research Journal of Basic and Clinical Studies. 2016 Mar: Vol.4 (1): pp. 010-013.
  16. Hitha B, Pappachan JM, Pillai HB, Sujathan P, Ramakrishna CD, Jayaprakash K, et al. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: An Indian experience. Saudi J Kidney Dis Transpl 2008; 19: 411‑9.
  17. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuriascreening by reagent strip predicts cardiovascular risk inhypertension. J Hypertens 1996; 14: 223-8.
  18. Maggon RR, Malik R, Jain N, Isser HS. Study of the Prevalence of Microalbuminuria in Patients of Essential Hypertension and its Correlation with Left Ventricular Hypertrophy and Carotid Artery Intima-media Thickness. Journal of Clinical and Preventive Cardiology. 2018 Jan 1;7(1):11.
  19. Gatzka CD, Reid CM, Lux A, Dart AM, Jennings GL. Leftventricular mass and microalbuminuria: Relation to ambulatoryblood pressure. Hypertension Diagnostic Service Investigators. ClinExp PharmacolPhysiol 1999; 26: 514‑6
Journal Menu MIJOMED Medpulse Manuscript Submission Subscription Aim & Scope Peer Review Process Publication Ethics & Malpractice Statement Open Access Statement Plagiarism Policy Editorial Board Indexing Current Issue Publication Charges Archives Authors Information Copyright & Licensing Privacy Statement Contact Us